The Maastricht Study: An extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities

European Journal of Epidemiology

Volumn 29, Issue 6, 2014, Pages 439-451

  Schram, Miranda T ^a,b   Sep, Simone J S ^a,b   Van Der Kallen, Carla J ^a,b   Dagnelie, Pieter C ^b,c   Koster, Annemarie ^c   Schaper, Nicolaas ^a,b,c   Henry, Ronald M A ^a,b   Stehouwer, Coen D A ^a,b,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiovascular disease; Chronic disease; Comorbidity; Pathophysiology; Prospective cohort study; Study design; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE;

ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMORBIDITY; ELECTROCARDIOGRAPHY; EYE FUNDUS; EYE PHOTOGRAPHY; GASTROINTESTINAL DISEASE; HUMAN; IMAGING; INFORMATION PROCESSING; INFORMED CONSENT; LABORATORY TEST; LIFESTYLE; MEDICAL ETHICS; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATIENT INFORMATION; PHENOTYPE; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SOCIAL PSYCHOLOGY; STUDY DESIGN; VIBRATION SENSE;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NETHERLANDS; PHENOTYPE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS;

EID: 84903520701     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-014-9889-0     Document Type: Article

References (69)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. (Pubitemid 38579764)
2. WHO. The global burden of disease: 2004 update. 2008. http://www.who.int/healthinfo/global-burden-disease/GBD-report-2004update-full. pdf.
3. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, Feigl AB, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein AZ, Weinstein C. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum; 2011.
4. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884-90. (Pubitemid 37430605)
5. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia. 2004;47(10):1747-59. (Pubitemid 40022410)
6. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829-41.
7. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596-615.
8. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378(9786):169-81. doi:10.1016/s0140-6736(11)60614-4.
9. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes. 2004;53(Suppl 3):S16-21. (Pubitemid 39564517)
10. Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev. 2013;9(1):25-53.
11. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-22. doi:10.1016/s0140-6736(10)60484-9.
12. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, et al. Nephropathy in diabetes. Diabetes Care. 2004;27(Suppl 1):S79-83.
13. Icks A, Haastert B, Trautner C, Giani G, Glaeske G, Hoffmann F. Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes. 2009;117(9):500-4. doi:10.1055/s-0029-1225333.
14. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844-51. doi:10.1590/S0042-96862004001100009. (Pubitemid 39573742)
15. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2011.
16. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database of Syst Rev. 2009;3:CD001841. doi:10.1002/14651858.CD001841.pub2.
17. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-78. doi:10.1016/S0140-6736(05)67394-1.
18. Carnethon MR, Biggs ML, Barzilay J, Kuller LH, Mozaffarian D, Mukamal K, et al. Diabetes and coronary heart disease as risk factors for mortality in older adults. Am J Med. 2010;123(6):556e1-9. doi:10.1016/j.amjmed.2009.11.023.
19. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219-29. doi:10.1016/S0140-6736(12)61031-9.
20. Lollgen H, Bockenhoff A, Knapp G. Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med. 2009;30(3):213-24. doi:10.1055/s-0028-1128150.
21. Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, Wilmot EG, et al. Association of sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS ONE. 2012;7(4):e34916. doi:10.1371/journal.pone.0034916.
22. Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, Gray LJ, et al. Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia. 2012. doi:10.1007/s00125-012-2677-z.
23. Bankoski A, Harris TB, McClain JJ, Brychta RJ, Caserotti P, Chen KY, et al. Sedentary activity associated with metabolic syndrome independent of physical activity. Diabetes Care. 2011;34(2):497-503.
24. Cooper AR, Sebire S, Montgomery AA, Peters TJ, Sharp DJ, Jackson N, et al. Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia. 2012;55(3):589-99. doi:10.1007/s00125-011-2408-x.
25. Healy GN, Wijndaele K, Dunstan DW, Shaw JE, Salmon J, Zimmet PZ, et al. Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care. 2008;31(2):369-71. doi:10.2337/dc07-1795. (Pubitemid 351213354)
26. Koster A, Caserotti P, Patel KV, Matthews CE, Berrigan D, Van Domelen DR, et al. Association of sedentary time with mortality independent of moderate to vigorous physical activity. PLoS ONE. 2012;7(6):e37696. doi:10.1371/journal. pone.0037696.
27. Gallo V, Mackenbach JP, Ezzati M, Menvielle G, Kunst AE, Rohrmann S, et al. Social inequalities and mortality in Europe-results from a large multi-national cohort. PLoS ONE. 2012;7(7):e39013. doi:10.1371/journal.pone. 0039013.
28. Espelt A, Borrell C, Roskam AJ, Rodriguez-Sanz M, Stirbu I, Dalmau-Bueno A, et al. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century. Diabetologia. 2008;51(11):1971-9. doi:10.1007/s00125-008-1146-1.
29. www.nhg.org/standaarden/samenvatting/cardiovasculair-risicomanagement.
30. van Keulen HM, Mesters I, Brug J, Ausems M, Campbell M, Resnicow K, et al. Vitalum study design: RCT evaluating the efficacy of tailored print communication and telephone motivational interviewing on multiple health behaviors. BMC Public Health. 2008;8:216. doi:10.1186/1471-2458-8-216.
31. van Keulen HM, Mesters I, Ausems M, van Breukelen G, Campbell M, Resnicow K, et al. Tailored print communication and telephone motivational interviewing are equally successful in improving multiple lifestyle behaviors in a randomized controlled trial. Ann Behav Med. 2011;41(1):104-18. doi:10.1007/s12160-010- 9231-3.
32. Resnicow K, McCarty F, Blissett D, Wang T, Heitzler C, Lee RE. Validity of a modified CHAMPS physical activity questionnaire among African-Americans. Med Sci Sports Exerc. 2003;35(9):1537-45. doi:10.1249/01.MSS.0000084419.64044. 2B. (Pubitemid 37087584)
33. Harada ND, Chiu V, King AC, Stewart AL. An evaluation of three self-report physical activity instruments for older adults. Med Sci Sports Exerc. 2001;33(6):962-70. (Pubitemid 32524711)
34. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247-63.
35. Ware JESK, Kosinski M, et al. SF-36 health survey manual and interpretation guide. Boston, MA: New England Medical Center; 1993.
36. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53-72. (Pubitemid 26191458)
37. Suurmeijer TP, Doeglas DM, Moum T, Briancon S, Krol B, Sanderman R, et al. The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health. 1994;84(8):1270-3. (Pubitemid 24250696)
38. WHO. Definition and Diagnosis of diabetes mellitus and intermediate hyperglycemia. 2006. www.whoint/diabetes/publications/ Definition%20and%20diagnosis%20of%20diabetes-newpdf.
39. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45(10):1101-9.
40. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36. doi:10.1016/j.pain.2004.12.010. (Pubitemid 40279084)
41. Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care. 2000;23(9):1305-9.
42. Van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J. Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc. 2005;11(3):290-302. (Pubitemid 40790621)
43. Luteijn F, Barelds DPH. GIT-2, Groninger intelligentietest 2. Handleiding. Amsterdam: Harcourt Test Publishers; 2004.
44. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment. 2006;13(1):62-79. (Pubitemid 43812615)
45. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. The concept shifting test: adult normative data. Psychol Assess. 2006;18(4):424-32. (Pubitemid 44950886)
46. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc. 2006;12(1):80-9. (Pubitemid 43379954)
47. van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J. The letter digit substitution test: normative data for 1,858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex. J Clin Exp Neuropsychol. 2006;28(6):998-1009. (Pubitemid 44034738)
48. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.
49. Derix T, Hijdra A. Camdex-N protocol. Cambridge Examination for Mental Disorders of the Elderly. 1992.
50. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33;quiz 4-57.
51. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-13. (Pubitemid 32823891)
52. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7. doi:10.1001/archinte.166.10.1092. (Pubitemid 43765180)
53. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53(3):537-42. (Pubitemid 29382048)
54. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia. 2004;24(Suppl 1):9-160.
55. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20-8. (Pubitemid 32240082)
56. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-38. doi:10.1056/NEJMoa0909883.
57. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-5.
58. Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004;13(10):1737-49. (Pubitemid 41215253)
59. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920-4. doi:10.3109/ 00365529709011203. (Pubitemid 27382038)
60. Molag ML, de Vries JH, Duif N, Ocke MC, Dagnelie PC, Goldbohm RA, et al. Selecting informative food items for compiling food-frequency questionnaires: comparison of procedures. Br J Nutr. 2010;104(3):446-56. doi:10.1017/ S0007114510000401.
61. Kersten P, Cardol M, George S, Ward C, Sibley A, White B. Validity of the impact on participation and autonomy questionnaire: a comparison between two countries. Disabil Rehabil. 2007;29(19):1502-9. doi:10.1080/09638280601030066. (Pubitemid 47456956)
62. McCallister L, Fischer CS. A procedure for surveying personal networks. Sociol Methods Res. 1978;7(2):131-48.
63. Goldberg LR. An alternative "description of personality": the big-five factor structure. J Pers Soc Psychol. 1990;59(6):1216-29.
64. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67(1):89-97. doi:10.1097/01.psy.0000149256.81953.49.
65. Lamberts PHG, Steenbakkers M, Thijssen NHB, Backus-Mujakovic S, de Vreede JJM, Hajema KJ, Poos MJJC. Een gezonde kijk op Zuid-Limburg. Regionale Volksgezondheid Toekomst Verkenning 2010. GGD Zuid-Limburg; 2010.
66. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403-22.
67. Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes. 2007;56(3):872-8. doi:10.2337/db06-0922. (Pubitemid 46348467)
68. Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ, et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study. Diabetes Care. 1995;18(9):1270-3.
69. Schram MT, Kostense PJ, Van Dijk RA, Dekker JM, Nijpels G, Bouter LM, et al. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens. 2002;20(9):1743-51.